Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia
NCT01579864 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2016-11-03
Summary
Myorelaxation is generally used as a part of general anesthesia for interventional rigid bronchoscopy. Succinylcholine is most often used because its short duration of action but rocuronium can be used since sugammadex permits a rapid and complete reversal of the neuromuscular block. The aim of ths study is to compare both agents.
Conditions
- Anesthesia
Interventions
- DRUG
-
succinylcholine
Succinylcholine 1 mg/kg and a second dose if necessary. Rocuronium 0,4 mg/kg can be used as a rescue
- DRUG
-
rocuronium
rocuronium 0,9 mg/kg with additional boluses of 0,3 mg/kg f necessary
Sponsors & Collaborators
-
Hopital Foch
lead OTHER
Principal Investigators
-
Morgan Le Guen, MD · Hopital Foch
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- France
Study Locations
More Related Trials
-
Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)
NCT01479764 ·Status: COMPLETED ·Phase: PHASE3
-
Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients
NCT03168308 ·Status: COMPLETED ·Phase: PHASE4
-
Interaction Between Magnesium and Neostigmine or Sugammadex for the Reversal of a Rocuronium-induced Neuromuscular Block
NCT03497923 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)
NCT00473694 ·Status: COMPLETED ·Phase: PHASE3
-
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
NCT02375217 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of Sugammadex in the Critically Ill
NCT03791801 ·Status: UNKNOWN ·Phase: NA
-
Sugammadex as Rescue Therapy
NCT05661409 ·Status: COMPLETED ·Phase: PHASE4
-
Sugammadex and Smoker's Neuromuscular Block
NCT05313100 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex
NCT02562417 ·Status: WITHDRAWN ·Phase: PHASE4
-
Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX)
NCT02589691 ·Status: RECRUITING ·Phase: PHASE4
-
Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Block
NCT05228223 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in Children
NCT04347486 ·Status: COMPLETED ·Phase: PHASE2
-
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
NCT05066035 ·Status: COMPLETED ·Phase: PHASE4
-
Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex
NCT01962298 ·Status: COMPLETED ·Phase: PHASE3
-
Residual Neuromuscular Blockade in Cardiac Surgery Patients
NCT03574337 ·Status: WITHDRAWN ·Phase: PHASE4
-
Sugammadex Dose Finding Under Two Years Old
NCT06575036 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
NCT03728543 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants
NCT02708056 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis
NCT06436768 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Sugammadex in Magnesium Pretreated Patients
NCT01440933 ·Status: COMPLETED ·Phase: PHASE2
-
Reversal With Sugammadex From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical Trial
NCT01809886 ·Status: COMPLETED ·Phase: PHASE3
-
Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex
NCT02932254 ·Status: COMPLETED ·Phase: PHASE4
-
MgSO4 Combined With Rocuronium Priming
NCT01389791 ·Status: UNKNOWN ·Phase: NA
-
Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children
NCT05724550 ·Status: COMPLETED ·Phase: NA
-
Reversal of Residual Neuromuscular Blockade at Train-of-four Ratio 0.3 With Sugammadex and Neostigmine
NCT03656614 ·Status: COMPLETED